Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 May 17;9(2):e14.
doi: 10.2196/jmir.9.2.e14.

Pilot randomized trial of the effect of wireless telemonitoring on compliance and treatment efficacy in obstructive sleep apnea

Carl J Stepnowsky  1 , Joe J Palau, Matthew R Marler, Allen L Gifford
Affiliations
Randomized Controlled Trial

Pilot randomized trial of the effect of wireless telemonitoring on compliance and treatment efficacy in obstructive sleep apnea

Carl J Stepnowsky et al. J Med Internet Res. .

Abstract

Background: Obstructive sleep apnea (OSA) is a prevalent and serious medical condition characterized by repeated complete or partial obstructions of the upper airway during sleep and is prevalent in 2% to 4% of working middle-aged adults. Nasal continuous positive airway pressure (CPAP) is the gold-standard treatment for OSA. Because compliance rates with CPAP therapy are disappointingly low, effective interventions are needed to improve CPAP compliance among patients diagnosed with OSA.

Objective: The aim was to determine whether wireless telemonitoring of CPAP compliance and efficacy data, compared to usual clinical care, results in higher CPAP compliance and improved OSA outcomes.

Methods: 45 patients newly diagnosed with OSA were randomized to either telemonitored clinical care or usual clinical care and were followed for their first 2 months of treatment with CPAP therapy. CPAP therapists were not blinded to the participants' treatment group.

Results: 20 participants in each group received the designated intervention. Patients randomized to telemonitored clinical care used CPAP an average of 4.1 +/- 1.8 hours per night, while the usual clinical care patients averaged 2.8 +/- 2.2 hours per night (P = .07). Telemonitored patients used CPAP on 78% +/- 22% of the possible nights, while usual care patients used CPAP on 60% +/- 32% of the nights (P = .07). No statistically significant differences between the groups were found on measures of CPAP efficacy, including measures of mask leak and the Apnea-Hypopnea Index. Patients in the telemonitored group rated their likelihood to continue using CPAP significantly higher than the patients in the usual care group. Patients in both groups were highly satisfied with the care they received and rated themselves as "not concerned" that their CPAP data were being wirelessly monitored.

Conclusions: Telemonitoring of CPAP compliance and efficacy data and rapid use of those data by the clinical sleep team to guide the collaborative (ie, patient and provider) management of CPAP treatment is as effective as usual care in improving compliance rates and outcomes in new CPAP users. This study was designed as a pilot-larger, well-powered studies are necessary to fully evaluate the clinical and economic efficacy of telemonitoring for this population.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Participant flow and randomization chart
Figure 2
Figure 2
Model of wireless telemonitoring of CPAP compliance and efficacy.
Figure 3
Figure 3
Screenshot of the ResTraxx Data Center website, showing the compliance tab with sample compliance and efficacy data for one month of CPAP use for a hypothetical patient. The thresholds specified on another tab allow for color-coding of efficacy and compliance data — this color-coding allows for quick review of how well any one patient is doing on CPAP. Specific data values are also provided, which can aid clinical management. The symbol legend at the bottom of the tab explains the meaning of each symbol used in this tab (see also Table 2).
See this image and copyright information in PMC

References

    1. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):685–9. http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=11254524 - PubMed
    1. Gibson G J. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull. 2004;72(1):49–65. doi: 10.1093/bmb/ldh044.72/1/49 - DOI - PubMed
    1. Marshall N S, Barnes M, Travier N, Campbell A J, Pierce R J, Mcevoy R D, Neill A M, Gander P H. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax. 2006 May;61(5):430–4. doi: 10.1136/thx.2005.050583. http://thorax.bmjjournals.com/cgi/pmidlookup?view=long&pmid=16467072thx.2005.050583 - DOI - PMC - PubMed
    1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230–5. doi: 10.1056/NEJM199304293281704. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=8464434&promo=ONF... - DOI - PubMed
    1. Nieto F J, Young T B, Lind B K, Shahar E, Samet J M, Redline S, D'agostino R B, Newman A B, Lebowitz M D, Pickering T G. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000 Apr 12;283(14):1829–36. doi: 10.1001/jama.283.14.1829. http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=10770144joc91797 - DOI - PubMed

Publication types